MedTech Solutions S.A. (WSE:MDT)
0.3160
+0.0020 (0.64%)
At close: Jul 3, 2026
MedTech Solutions Balance Sheet
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.27 | 1.66 | 0.09 | 0.4 | 0.01 | 0.01 |
Short-Term Investments | 0.16 | 0.16 | - | 0.05 | 0.16 | - |
Cash & Short-Term Investments | 0.43 | 1.82 | 0.09 | 0.46 | 0.17 | 0.01 |
Cash Growth | 46.73% | 1842.24% | -79.54% | 172.15% | 1102.43% | 1300.00% |
Accounts Receivable | 0.78 | 0.58 | 0.06 | 0.05 | 0.07 | 0.14 |
Other Receivables | 0.46 | 0.29 | 0.11 | 0.06 | 0.06 | - |
Receivables | 1.24 | 0.87 | 0.17 | 0.12 | 0.13 | 0.14 |
Inventory | 2.36 | 0.85 | 0.18 | 0.23 | - | - |
Total Current Assets | 4.04 | 3.54 | 0.44 | 0.81 | 0.3 | 0.15 |
Property, Plant & Equipment | 0.01 | - | - | - | - | - |
Other Intangible Assets | 0.23 | 0.25 | 0.13 | 0.17 | - | - |
Long-Term Deferred Tax Assets | - | - | 0.01 | 0.01 | 0.01 | 0.01 |
Other Long-Term Assets | - | - | 0.25 | 0.25 | 0.1 | - |
Total Assets | 4.28 | 3.78 | 0.82 | 1.24 | 0.41 | 0.16 |
Accounts Payable | 1.46 | 0.48 | 0.28 | 0.2 | 0.08 | 0.1 |
Accrued Expenses | 0.11 | 0.09 | 0.06 | 0.05 | 0.03 | 0 |
Short-Term Debt | - | - | - | 0.06 | 0.25 | - |
Current Income Taxes Payable | 0.26 | 0.42 | 0.09 | 0.05 | 0.01 | - |
Other Current Liabilities | 0.07 | 0.08 | 0.12 | 0.03 | 0.03 | 0.11 |
Total Current Liabilities | 1.89 | 1.07 | 0.54 | 0.4 | 0.4 | 0.22 |
Long-Term Deferred Tax Liabilities | - | - | 0 | 0 | 0 | - |
Other Long-Term Liabilities | 0.02 | - | 0.79 | - | - | -0 |
Total Liabilities | 1.91 | 1.07 | 1.33 | 0.41 | 0.4 | 0.22 |
Common Stock | 7.55 | 7.55 | 14 | 14 | 12.38 | 12.08 |
Additional Paid-In Capital | 17.12 | 17.12 | 17.12 | 17.12 | 17.12 | 17.12 |
Retained Earnings | -28.05 | -27.7 | -37.37 | -36.03 | -35.23 | -35 |
Comprehensive Income & Other | 5.74 | 5.74 | 5.74 | 5.74 | 5.74 | 5.74 |
Shareholders' Equity | 2.37 | 2.71 | -0.51 | 0.83 | 0.01 | -0.06 |
Total Liabilities & Equity | 4.28 | 3.78 | 0.82 | 1.24 | 0.41 | 0.16 |
Total Debt | - | - | - | 0.06 | 0.25 | - |
Net Cash (Debt) | 0.43 | 1.82 | 0.09 | 0.39 | -0.08 | 0.01 |
Net Cash Growth | - | 1842.24% | -76.19% | - | - | - |
Net Cash Per Share | 0.01 | 0.02 | 0.01 | 0.04 | -0.01 | 0.00 |
Filing Date Shares Outstanding | 75.5 | 75.5 | 10 | 10 | 8.84 | 8.63 |
Total Common Shares Outstanding | 75.5 | 75.5 | 10 | 10 | 8.84 | 8.63 |
Working Capital | 2.15 | 2.47 | -0.1 | 0.4 | -0.1 | -0.07 |
Book Value Per Share | 0.03 | 0.04 | -0.05 | 0.08 | 0.00 | -0.01 |
Tangible Book Value | 2.13 | 2.47 | -0.64 | 0.66 | 0.01 | -0.06 |
Tangible Book Value Per Share | 0.03 | 0.03 | -0.06 | 0.07 | 0.00 | -0.01 |